EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Potential of Single-Transcription Factor Gene Expression by RT-qPCR for Subtyping Small Cell Lung Cancer

Albert Iñañez iD, Raúl Del Rey-Vergara iD, Fabricio Quimis, Pedro Rocha, Miguel Galindo iD, Sílvia Menéndez, Laura Masfarré, Ignacio Sánchez, Marina Carpes, Carlos Martínez iD, Sandra Pérez-Buira, Federico Rojo und 2 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26031293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Albert Iñañez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Program, Hospital del Mar Research Institute, 08003 Barcelona, Spain. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms, Basic Helix-Loop-Helix Proteins, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo de Investigación Sanitaria, Instituto de Salud Carlos III (ISCiii), Agència de Gestió Ajuts Universitaris de Recerca, Generalitat de Catalunya.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Complex RNA-seq signatures involving the transcription factors ASCL1, NEUROD1, and POU2F3 classify Small Cell Lung Cancer (SCLC) into four subtypes: SCLC-A, SCLC-N, SCLC-P, and SCLC-I (triple negative or inflamed). Preliminary studies suggest that identifying these subtypes can guide targeted therapies and potentially improve outcomes. This study aims to evaluate whether the expression levels of these three key transcription factors can effectively classify SCLC subtypes, comparable to the use of individual antibodies in immunohistochemical (IHC) analysis of formalin-fixed, paraffin-embedded (FFPE) tumor samples. We analyzed preclinical models of increasing complexity, including eleven human and five mouse SCLC cell lines, six patient-derived xenografts (PDXs), and two circulating tumor cell (CTC)-derived xenografts (CDXs) generated in our laboratory. RT-qPCR conditions were established to detect the expression levels of ASCL1, NEUROD1, and POU2F3. Additionally, protein-level analysis was performed using Western blot for cell lines and IHC for FFPE samples of PDX and CDX tumors, following our experience with patient tumor samples from the CANTABRICO trial (NCT04712903). We found that the analyzed SCLC cell line models predominantly expressed ASCL1, NEUROD1, and POU2F3, or showed no expression, as identified by RT-qPCR, consistently matching the previously assigned subtypes for each cell line. The classification of PDX and CDX models demonstrated consistency between RT-qPCR and IHC analyses of the transcription factors. Our results show that single-gene analysis by RT-qPCR from FFPE-extracted RNA simplifies SCLC subtype classification. This approach provides a cost-effective alternative to IHC staining or expensive multi-gene RNA sequencing panels, making SCLC subtyping more accessible for both preclinical research and clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Cell Lung CarcinomaLung NeoplasmsBasic Helix-Loop-Helix ProteinsGene Expression Regulation, NeoplasticTranscription FactorsHumansAnimalsMiceCell Line, TumorReal-Time Polymerase Chain ReactionBiomarkers, TumorNeoplastic Cells, Circulating

Stichwörter der Autor:innen

ASCL1NEUROD1POU2F3RT-qPCRSCLC subtypessingle-gene marker

Substanzen

Basic Helix-Loop-Helix ProteinsTranscription FactorsBiomarkers, TumorASCL1 protein, humanNEUROD1 protein, human

Autor:innen und Institutionen

  • Cancer Research Program, Hospital del Mar Research Institute, 08003 Barcelona, Spain.
  • Department of Medical Oncology, Hospital del Mar, 08003 Barcelona, Spain.
  • Department of Pathology, Hospital del Mar, 08003 Barcelona, Spain.
  • Instituto Murciano de Investigación Biosanitaria IMIB-Pascual Parrilla, Pathology Core, 30120 Murcia, Spain.
  • Department of Anatomy and Comparative Pathology, Facultad de Veterinaria, Universidad de Murcia, 30100 Murcia, Spain.
  • Department of Pathology, IIS-Fundación Jiménez Díaz-CIBERONC, 28040 Madrid, Spain.

ORCID-Profile: Albert Iñañez, Raúl Del Rey-Vergara, Miguel Galindo, Carlos Martínez, Edurne Arriola

Förderung

  • Fondo de Investigación Sanitaria
  • Instituto de Salud Carlos III (ISCiii)
  • Agència de Gestió Ajuts Universitaris de Recerca, Generalitat de Catalunya
  • Fondo de Investigación Sanitaria, Spanish Ministry of Health projects
  • European Union
  • Centro de Investigación Biomédica en Red Cáncer
  • Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya
  • doctoral training fellowship (Contratos Predoctorales de Formación en Investigación en Salud, PFIS)

Zitieren

APA

Iñañez, A., Del Rey-Vergara, R., Quimis, F., Rocha, P., Galindo, M., Menéndez, S., Masfarré, L., Sánchez, I., Carpes, M., Martínez, C., Pérez-Buira, S., Rojo, F., Rovira, A., & Arriola, E. (2025). The Potential of Single-Transcription Factor Gene Expression by RT-qPCR for Subtyping Small Cell Lung Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031293

Vancouver

Iñañez A, Del Rey-Vergara R, Quimis F, Rocha P, Galindo M, Menéndez S, et al. The Potential of Single-Transcription Factor Gene Expression by RT-qPCR for Subtyping Small Cell Lung Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031293

BibTeX
@article{Iaez2025,
  author = {Iñañez, Albert and Del Rey-Vergara, Raúl and Quimis, Fabricio and Rocha, Pedro and Galindo, Miguel and Menéndez, Sílvia and Masfarré, Laura and Sánchez, Ignacio and Carpes, Marina and Martínez, Carlos and Pérez-Buira, Sandra and Rojo, Federico and Rovira, Ana and Arriola, Edurne},
  title = {The Potential of Single-Transcription Factor Gene Expression by RT-qPCR for Subtyping Small Cell Lung Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26031293}
}
Kostenlos starten →